Krensavage Asset Management, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1609251 NEW YORK, NY

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,508,400

-$1,072,500 QoQ

Shares Held

280,681

-10.5% QoQ

Ownership

0.484%

of shares outstanding

% of Portfolio

5.67%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Krensavage Asset Management, LLC holds $79,296,778 across 5 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (18.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	84,282	$49,977,540
2	SUPN	Supernus Pharmaceuticals, Inc. This page	280,681	$14,508,400
3	INDV	Indivior Pharmaceuticals, Inc.	339,532	$10,348,935
4	ALKS	Alkermes plc.	107,822	$3,812,585
5	EOLS	Evolus, Inc.	157,985	$649,318

All Filings in SUPN

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,508,400	280,681	-10.5%	Shares	Sole	2026-05-15
2025-12-31	$15,580,900	313,499	-13.8%	Shares	Sole	2026-02-18
2025-09-30	$17,370,661	363,479	-23.1%	Shares	Sole	2025-11-17
2025-06-30	$14,889,291	472,376	+9.3%	Shares	Sole	2025-08-15
2025-03-31	$14,147,541	431,986	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.